4.7 Article

Resting-state brain function in schizophrenia and psychotic bipolar probands and their first-degree relatives

Journal

PSYCHOLOGICAL MEDICINE
Volume 45, Issue 1, Pages 97-108

Publisher

CAMBRIDGE UNIV PRESS
DOI: 10.1017/S003329171400110X

Keywords

Bipolar disorder; brain function; magnetic resonance imaging; relatives; resting state; schizophrenia

Funding

  1. National Institute of Mental Health [MH078113, MH077945, MH077852, MH077851, MH077862, MH072767, MH083888]
  2. National Natural Science Foundation (China) [81222018, 81371527, 81030027, 81227002, 81220108013]
  3. Intracellular Therapies (ITI, Inc.)
  4. PureTech Ventures
  5. Eli Lilly
  6. Sunovion
  7. Astellas
  8. Merck
  9. International Congress on Schizophrenia Research
  10. National Alliance on Mental Illness
  11. American Psychiatric Association
  12. Finnegan Henderson Farabow Garrett Dunner, LLP.
  13. GlaxoSmithKline
  14. Takeda
  15. Pfizer
  16. BMS
  17. Janssen
  18. Allon
  19. AstraZeneca
  20. Department of Veterans' Affairs
  21. Feinstein Institute for Medical Research
  22. National Institute of Mental Health, Novartis, Psychogenics
  23. Research Foundation for Mental Hygiene, Inc.
  24. Singapore National Medical Research Council

Ask authors/readers for more resources

Background. Schizophrenia (SCZ) and psychotic bipolar disorder (PBD) share considerable overlap in clinical features, genetic risk factors and co-occurrence among relatives. The common and unique functional cerebral deficits in these disorders, and in unaffected relatives, remain to be identified. Method. A total of 59 healthy controls, 37 SCZ and 57 PBD probands and their unaffected first-degree relatives (38 and 28, respectively) were studied using resting-state functional magnetic resonance imaging (rfMRI). Regional cerebral function was evaluated by measuring the amplitude of low-frequency fluctuations (ALFF). Areas with ALFF alterations were used as seeds in whole-brain functional connectivity analysis. We then tested whether abnormalities identified in probands were present in unaffected relatives. Results. SCZ and PBD probands both demonstrated regional hypoactivity in the orbital frontal cortex and cingulate gyrus, as well as abnormal connectivity within striatal-thalamo-cortical networks. SCZ probands showed greater and more widely distributed ALFF alterations including the thalamus and bilateral parahippocampal gyri. Increased parahippocampal ALFF was related to positive symptoms and cognitive deficit. PBD patients showed uniquely increased functional connectivity between the thalamus and bilateral insula. Only PBD relatives showed abnormal connectivity within striatal-thalamo-cortical networks seen in both proband groups. Conclusions. The present findings reveal a common pattern of deficits in frontostriatal circuitry across SCZ and PBD, and unique regional and functional connectivity abnormalities that distinguish them. The abnormal network connectivity in PBD relatives that was present in both proband groups may reflect genetic susceptibility associated with risk for psychosis, but within-family associations of this measure were not high.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available